THIRONA THERAPEUTICS Trademark

Trademark Overview

On Wednesday, June 2, 2021, a trademark application was filed for THIRONA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the THIRONA THERAPEUTICS trademark a serial number of 90750305. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, October 14, 2024. This trademark is owned by Thirona Pharmaceuticals, LLC. The THIRONA THERAPEUTICS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals for others

Pharmaceutical research and development
thirona therapeutics

General Information

Serial Number90750305
Word MarkTHIRONA THERAPEUTICS
Filing DateWednesday, June 2, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceuticals for others
NOT AVAILABLE"THERAPRUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThirona Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHollywood, FL 33024
Party NameThirona Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHollywood, FL 33024

Trademark Events

Event DateEvent Description
Monday, January 17, 2022EXAMINERS AMENDMENT E-MAILED
Saturday, June 5, 2021NEW APPLICATION ENTERED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 10, 2022ASSIGNED TO EXAMINER
Monday, January 17, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, January 17, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 17, 2022EXAMINER'S AMENDMENT ENTERED
Monday, January 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, October 10, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 10, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 10, 2022SOU EXTENSION 1 FILED
Wednesday, October 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 2 GRANTED
Thursday, April 13, 2023SOU EXTENSION 2 FILED
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024SOU EXTENSION 4 GRANTED
Thursday, April 11, 2024SOU EXTENSION 4 FILED
Friday, April 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 16, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 16, 2023SOU EXTENSION 3 FILED
Monday, October 16, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 14, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 14, 2024SOU EXTENSION 5 GRANTED
Monday, October 14, 2024SOU EXTENSION 5 FILED

Related Keywords

therapeutics thirona research development pharmaceutical others manufacture pharmaceuticals custom